Purple Biotech Reports Third Quarter 2026 Financial Results and Provides Business Update
IM1240 tri-specific antibody (capped-CD3x5T4xNKG2A): Investigational New Drug (IND) application subm
IM1240 tri-specific antibody (capped-CD3x5T4xNKG2A): Investigational New Drug (IND) application subm